Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer by Beck T. et al.
Article
Anti-M€ullerian Hormone Signaling Regulates
Epithelial Plasticity and Chemoresistance in Lung
Cancer
Graphical Abstract
Highlights
d TGF-b superfamily member AMH regulates tumor growth and
drug resistance in NSCLC
d AMH and AMHR2 activity influences SMAD, AKT, and NF-kB
signaling in NSCLC cells
d Loss of AMH/AMHR2 promotes EMT through direct
modulation of TGF-b/BMP receptors
d EMT promotes chemoresistance, but sensitizes NSCLC cells
to HSP90 inhibition
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In Brief
Beck et al. identify active signaling by the
TGF-b/BMP superfamily member anti-
M€ullerian hormone (AMH) and its receptor
AMHR2 in non-small cell lung cancer
(NSCLC), demonstrating a role for AMH/
AMHR2 in influencing the basal and BMP-
dependent SMAD signaling that
constrains epithelial-mesenchymal
transition (EMT) and in regulating drug
resistance.
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